|
Longitudinal personalized urinary tumor DNA analysis in muscle-invasive bladder cancer from the neoadjuvant immunotherapy trial RJBLC-I2N003. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Huidu Shanghai Medical Sciences |
|
|
Employment - Huidu Shanghai Medical Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Predicine |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |